Research ArticleArticle
Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity
David E. Durrant, Anindita Das, Samya Dyer, Seyedmehrad Tavallai, Paul Dent and Rakesh C. Kukreja
Molecular Pharmacology September 2015, 88 (3) 512-523; DOI: https://doi.org/10.1124/mol.115.099143
David E. Durrant
Department of Biochemistry and Molecular Biology (D.E.D., S.T., P.D.), Department of Internal Medicine, Division of Cardiology, Pauley Heart Center (A.D., S.D., R.C.K.), and Department of Physiology and Biophysics (R.C.K.), Virginia Commonwealth University Medical Center, Richmond, Virginia
Anindita Das
Department of Biochemistry and Molecular Biology (D.E.D., S.T., P.D.), Department of Internal Medicine, Division of Cardiology, Pauley Heart Center (A.D., S.D., R.C.K.), and Department of Physiology and Biophysics (R.C.K.), Virginia Commonwealth University Medical Center, Richmond, Virginia
Samya Dyer
Department of Biochemistry and Molecular Biology (D.E.D., S.T., P.D.), Department of Internal Medicine, Division of Cardiology, Pauley Heart Center (A.D., S.D., R.C.K.), and Department of Physiology and Biophysics (R.C.K.), Virginia Commonwealth University Medical Center, Richmond, Virginia
Seyedmehrad Tavallai
Department of Biochemistry and Molecular Biology (D.E.D., S.T., P.D.), Department of Internal Medicine, Division of Cardiology, Pauley Heart Center (A.D., S.D., R.C.K.), and Department of Physiology and Biophysics (R.C.K.), Virginia Commonwealth University Medical Center, Richmond, Virginia
Paul Dent
Department of Biochemistry and Molecular Biology (D.E.D., S.T., P.D.), Department of Internal Medicine, Division of Cardiology, Pauley Heart Center (A.D., S.D., R.C.K.), and Department of Physiology and Biophysics (R.C.K.), Virginia Commonwealth University Medical Center, Richmond, Virginia
Rakesh C. Kukreja
Department of Biochemistry and Molecular Biology (D.E.D., S.T., P.D.), Department of Internal Medicine, Division of Cardiology, Pauley Heart Center (A.D., S.D., R.C.K.), and Department of Physiology and Biophysics (R.C.K.), Virginia Commonwealth University Medical Center, Richmond, Virginia
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
BEZ235 Augments Doxorubicin without Influencing Cardiotoxicity
David E. Durrant, Anindita Das, Samya Dyer, Seyedmehrad Tavallai, Paul Dent and Rakesh C. Kukreja
Molecular Pharmacology September 1, 2015, 88 (3) 512-523; DOI: https://doi.org/10.1124/mol.115.099143
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement